227 related articles for article (PubMed ID: 35121725)
21. ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
Su H; Shu S; Tang W; Zheng C; Zhao L; Fan H
Biochem Biophys Res Commun; 2023 Dec; 684():149137. PubMed ID: 37897911
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
[TBL] [Abstract][Full Text] [Related]
23. HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro.
Yang S; Liu Y; Feng X; Wang X; Wu M; Gong L; Shu B; Lu Q; Dong J
Dig Liver Dis; 2021 Mar; 53(3):360-366. PubMed ID: 33153927
[TBL] [Abstract][Full Text] [Related]
24. TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p.
Song W; Zheng C; Liu M; Xu Y; Qian Y; Zhang Z; Su H; Li X; Wu H; Gong P; Li Y; Fan H
Mol Ther; 2021 Aug; 29(8):2601-2616. PubMed ID: 33839325
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.
Bak Y; Shin HJ; Bak Is; Yoon DY; Yu DY
Biochem Biophys Res Commun; 2015 Oct; 466(4):676-81. PubMed ID: 26392315
[TBL] [Abstract][Full Text] [Related]
27. HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
Huang P; Xu Q; Yan Y; Lu Y; Hu Z; Ou B; Zhang H; Mao K; Zhang J; Wang J; Xiao Z
Oncogene; 2020 Apr; 39(18):3774-3789. PubMed ID: 32157216
[TBL] [Abstract][Full Text] [Related]
28. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
[TBL] [Abstract][Full Text] [Related]
31. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
[TBL] [Abstract][Full Text] [Related]
32. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
[TBL] [Abstract][Full Text] [Related]
33. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
[TBL] [Abstract][Full Text] [Related]
34. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
35. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
36. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract][Full Text] [Related]
37. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.
Cheng F; Qian G; Fang X; Sun J; Chen S; Chen R; Liu S; Li Z; Wu K; Jiang S; Chen Y; Tang N; Chen J; Duan C
Hepatol Int; 2021 Jun; 15(3):707-719. PubMed ID: 33876395
[TBL] [Abstract][Full Text] [Related]
38. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
39. Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?
Arzumanyan A; Friedman T; Ng IO; Clayton MM; Lian Z; Feitelson MA
Cancer Res; 2011 May; 71(10):3701-8. PubMed ID: 21464043
[TBL] [Abstract][Full Text] [Related]
40. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
